| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | g2/mitotic-specific cyclin b1 | NA | Patented-recorded target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | g1/s-specific cyclin-d1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | cyclin-dependent kinase 1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | cyclin-dependent kinase 4 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | cyclin-dependent kinase 6 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | epidermal growth factor receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | erbb2 messenger rna | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | protein kinase c alpha | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | protein kinase c epsilon | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | protein kinase c gamma | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 3,4-diphenyl-1h-pyrrole-2,5-dione | angiopoietin 1 receptor | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| click here to return to the previous page | ||||||||